New treatment option for Rotator Cuff Related Shoulder Pain
Official title Exercise-induced Hypoalgesia Effects of Blood Flow Restriction in People With Rotator Cuff-related Shoulder Pain
ClinicalTrials.gov ID: NCT07232511
What this study is testing
- What it's testing
- This study aims to compare the effects of blood flow restricted (BFR) exercise and to examine the differences between various BFR protocols on acute pain reduction in individuals with rotator cuff-related shoulder pain, as well as the exercise tolerance at each intensity and occlusion setting. There are four exercise modalities corresponding to different combinations of intensity (%RM) and percentage of occlusion (%AOP): 1) 30% RM and 30% AOP; 2) 30% RM and 50% AOP; 3) 30% RM and 70% AOP; 4) 30% RM and BFR placebo (cuff without pressure).
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65
- Shoulder symptoms lasting at least 3 months
- Pain in the proximal anterolateral aspect of the shoulder, aggravated by abduction
- At least two of the following tests positive: Jobe test, resisted external rotation test, Hawkins-Kennedy test, Neer test, painful arc between 60 and...
You likely can't join if
- History of shoulder trauma or surgery
- Pain of such intensity that it is impossible to perform the proposed exercises
- Active arm elevation less than 90 degrees
- Clinical signs of a complete tear (positive delayed external and internal rotation sign and positive arm drop test)
- Suspected frozen shoulder (50% reduction or more than 30° loss in passive shoulder external rotation)
- Primary diagnosis of shoulder instability or acromioclavicular pathology
See the full eligibility criteria
- Age between 18 and 65
- Shoulder symptoms lasting at least 3 months
- Pain in the proximal anterolateral aspect of the shoulder, aggravated by abduction
- At least two of the following tests positive: Jobe test, resisted external rotation test, Hawkins-Kennedy test, Neer test, painful arc between 60 and 120 degrees of shoulder abduction
- History of shoulder trauma or surgery
- Pain of such intensity that it is impossible to perform the proposed exercises
- Active arm elevation less than 90 degrees
- Clinical signs of a complete tear (positive delayed external and internal rotation sign and positive arm drop test)
- Suspected frozen shoulder (50% reduction or more than 30° loss in passive shoulder external rotation)
- Primary diagnosis of shoulder instability or acromioclavicular pathology
- Shoulder pain due to primary involvement in the cervical or thoracic region
- Corticosteroid injections in the last 6 weeks
- Presence of diseases such as inflammatory arthritis, neurological diseases, fibromyalgia, malignant tumors, or polymyalgia rheumatica
- Presence of more than one risk factor for thromboembolism
- Participation in upper limb exercise programs in the last month
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.